| 000 | 01136 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513042409.0 | ||
| 264 | 0 | _c19950619 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0828-282X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarkentin, T E | |
| 245 | 0 | 0 |
_aHemostasis and atherosclerosis. _h[electronic resource] |
| 260 |
_bThe Canadian journal of cardiology _cMay 1995 |
||
| 300 |
_a29C-34C p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aArteriosclerosis _xblood |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xblood |
| 650 | 0 | 4 | _aBlood Coagulation Factors |
| 650 | 0 | 4 | _aFactor VII |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xanalysis |
| 650 | 0 | 4 |
_aHemostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoprotein(a) _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPlatelet Adhesiveness |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombosis _xetiology |
| 650 | 0 | 4 |
_avon Willebrand Factor _xanalysis |
| 773 | 0 |
_tThe Canadian journal of cardiology _gvol. 11 Suppl C _gp. 29C-34C |
|
| 999 |
_c7749416 _d7749416 |
||